ASCO GI 2023 Conference Coverage

 

ASCO GI 2023 Conference Coverage
S

ASCO GI 2023 Randomized Phase III FIRE-4 study (AIO KRK-0114): Investigating a Switch Maintenance Concept With 5-FU + Bev After FOLFIRI + Cet Induction Treatment vs. Continued Treatment With FOLFIRI + Cet in RAS-wt mCRC

By ASCO GI 2023 Conference Coverage FEATURING Sebastian Stintzing
By ASCO GI 2023 Conference Coverage FEATURING Sebastian Stintzing
361 views
January 23, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Videos
07:46

ASCO GI 2023 Phase II Clinical Trial to Study the Use of Cabozantini…

ASCO GI 2023 Conference Coverage

S. L. Chan

506 views
12:04

ASCO GI 2023 Preliminary Efficacy and Correlative Results of the Pha…

ASCO GI 2023 Conference Coverage

K. Spencer

96 views
06:17

ASCO GI 2023 INTEGRATE IIa Randomised, Double-Blind, Phase III Study…

ASCO GI 2023 Conference Coverage

N. Pavlakis

147 views
06:25

ASCO GI 2023 Overall Survival in Gastrointestinal Neuroendocrine Tum…

ASCO GI 2023 Conference Coverage

B. Laderian

164 views
05:13

ASCO GI 2023 Primary Endpoint Results of a Randomized, Double-Blind,…

ASCO GI 2023 Conference Coverage

J. Furuse

56 views
13:21

ASCO GI 2023 TIMES Trial: Advancing Precision Immunotherapy for Gast…

ASCO GI 2023 Conference Coverage

D. Zeng

150 views
09:24

ASCO GI 2023 Randomized Phase II VELO Clinical Trial: Panitumumab + …

ASCO GI 2023 Conference Coverage

S. Napolitano

146 views
11:02

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

ASCO GI 2023 Conference Coverage

Y. Y. Janjigian

598 views
30:57

ASCO GI 2023 Final Surgical Salvage Results From OPERA Phase 3 Rando…

ASCO GI 2023 Conference Coverage

A. Sun Myint

221 views
08:54

ASCO GI 2023 CRC Highlights: Phase 3 SUNLIGHT & PARADIGM Trials

ASCO GI 2023 Conference Coverage

A. Venook

513 views
09:02

ASCO GI 2023: A Study of Pembro in Combination With Y90 Radioemboliz…

ASCO GI 2023 Conference Coverage

A. Somasundaram

161 views
05:56

ASCO GI 2023 Phase II IMMULAB Trial: IO With Pembro in Combination W…

ASCO GI 2023 Conference Coverage

A. Vogel

101 views
05:26

ASCO GI 2023 Results From the TAPUR Study: Pertuzumab + Trastuzumab …

ASCO GI 2023 Conference Coverage

T. Cannon

166 views
10:19

ASCO GI 2023 Promoting Multidisciplinary Care for Patients With Unre…

ASCO GI 2023 Conference Coverage

A. Baron

55 views
07:46

FGFR2-Amplified Gastroesophageal Adenocarcinoma Is a Distinct Genomi…

ASCO GI 2023 Conference Coverage

B. Shariff

61 views
06:59

ASCO GI 2023 CCTG HE.1 - Phase 3 Study: Palliative RT for Symptomati…

ASCO GI 2023 Conference Coverage

L. Dawson

80 views
09:43

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

ASCO GI 2023 Conference Coverage

L. Dawson

442 views
05:32

ASCO GI 2023 Continuous Maintenance Capecitabine Dosing for Advanced…

ASCO GI 2023 Conference Coverage

R. Mukherji

128 views
20:09

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

ASCO GI 2023 Conference Coverage

K. Shiu

149 views
04:06

ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerabil…

ASCO GI 2023 Conference Coverage

J. Hubbard

43 views
06:08

ASCO GI 2023 Survival Outcomes and Functional Results of VOLTAGE-A: …

ASCO GI 2023 Conference Coverage

Y. Tsukada

78 views
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views
10:41

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

ASCO GI 2023 Conference Coverage

Z. Wainberg

398 views
07:49

ASCO GI 2023 Preliminary Clinical Results of the NERDY Study: Immuno…

ASCO GI 2023 Conference Coverage

A. Anna Prete

74 views
05:32

ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cispla…

ASCO GI 2023 Conference Coverage

R. Shroff

255 views
05:29

ASCO GI 2023 Phase 3 BREAKWATER Study Safety Lead-In: Encorafenib + …

ASCO GI 2023 Conference Coverage

S. Kopetz

663 views
16:19

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …

ASCO GI 2023 Conference Coverage

K. Reiss Binder

134 views
08:15

ASCO GI 2023 Zanidatamab + Chemo as 1L Treatment for HER2-Expressing…

ASCO GI 2023 Conference Coverage

E. Elimova

126 views
04:20

ASCO GI 2023 Final Results of the Phase II RE-ExPEL Study: Ramucirum…

ASCO GI 2023 Conference Coverage

T. Oliver Götze

171 views
12:31

ASCO GI 2023 29-Month Follow-Up From CheckMate 648: Nivo + Chemo or …

ASCO GI 2023 Conference Coverage

K. Kato

108 views
07:20

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…

ASCO GI 2023 Conference Coverage

R. Mehta

505 views
06:52

ASCO GI 2023 Multicenter, Single-Arm, Multi-Cohort, Phase II INFINIT…

ASCO GI 2023 Conference Coverage

F. Pietrantonio

222 views
11:46

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

ASCO GI 2023 Conference Coverage

A. Shergill

199 views
09:47

ASCO GI 2023 Neoadjuvant Immunotherapy in Localized dMMR CRC

ASCO GI 2023 Conference Coverage

S. Chakrabarti

179 views
09:12

ASCO GI 2023 Comparative Analysis of the Molecular Profile and Tumor…

ASCO GI 2023 Conference Coverage

A. Alqahtani

203 views
04:46

ASCO GI 2023 Confidence Study: Effectiveness & Safety of Encorafenib…

ASCO GI 2023 Conference Coverage

A. Fernandez Montes

94 views
07:58

ASCO GI 2023 ctDNA Dynamics and Clinical Outcome in mCRC Patients Un…

ASCO GI 2023 Conference Coverage

M. Ghidini

103 views
09:41

ASCO GI 2023 New Prognostic Index of Advanced Gastric Cancer Using t…

ASCO GI 2023 Conference Coverage

D. Takahari

126 views
04:41

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 …

ASCO GI 2023 Conference Coverage

M. Bouattour

304 views
12:06

ASCO GI 2023 Surgical Viewpoint on Non-Operative Management of Recta…

ASCO GI 2023 Conference Coverage

T. Konishi

80 views
27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views
05:34

ASCO GI 2023 Biomarker Study of The Phase III PARADIGM Trial: Negati…

ASCO GI 2023 Conference Coverage

K. Shitara

328 views
07:51

ASCO GI 2023 Phase 3 SPOTLIGHT Study Primary Results: Zolbetuximab +…

ASCO GI 2023 Conference Coverage

K. Shitara

489 views
07:40

ASCO GI 2023 Kinetics of Postoperative Circulating cfDNA and Impact …

ASCO GI 2023 Conference Coverage

S. Cohen

69 views
06:32

ASCO GI 2023 Analysis of HLA Gene Expression in Patients With dMMR/M…

ASCO GI 2023 Conference Coverage

H. Lenz

105 views
07:43

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

ASCO GI 2023 Conference Coverage

J. Alvarez

130 views
06:55

ASCO GI 2023 Evaluation of Clinical Benefit and PFS Ratio of Targete…

ASCO GI 2023 Conference Coverage

M. Niger

90 views
05:19

ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With At…

ASCO GI 2023 Conference Coverage

J. Hecht

391 views
10:26

Phase 3 Randomized SUNLIGHT Study: Trifluridine/Tipiracil + Bevacizu…

ASCO GI 2023 Conference Coverage

J. Tabernero

533 views
06:16

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

ASCO GI 2023 Conference Coverage

P. Romesser

360 views
06:55

ASCO GI 2023 Results From a Phase 1a/1b Study: Botensilimab, a Novel…

ASCO GI 2023 Conference Coverage

A. El-Khoueiry

157 views
10:41

ASCO GI 2023 Phase 2, Randomized, Double-Blind, Placebo-Controlled I…

ASCO GI 2023 Conference Coverage

A. El-Khoueiry

202 views
08:47

ASCO GI 2023 Use of ctDNA for Early Assessment of Treatment Response…

ASCO GI 2023 Conference Coverage

P. Kasi

120 views
13:36

ASCO GI 2023 CTCs as Liquid Biopsies in Patients With mCRC vs. Other…

ASCO GI 2023 Conference Coverage

P. Kasi

149 views
06:32

ASCO GI 2023 Randomized Phase III FIRE-4 study (AIO KRK-0114): Inves…

ASCO GI 2023 Conference Coverage

S. Stintzing

361 views
06:28

ASCO GI 2023 Survival Analysis of the Phase II Randomized DEEPER Tri…

ASCO GI 2023 Conference Coverage

Y. Sunakawa

309 views